Drugs

Page 4 of 28

Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By Lindsey Leake

January 22, 2025

Biden sets clemency record by commuting sentences of nearly 2,500 people convicted of nonviolent drug crimes

Biden sets clemency record by commuting sentences of nearly 2,500 people convicted of nonviolent drug crimes

By Will Weissert and The Associated Press

January 17, 2025

Close up of RFK Jr. speaking against a blue background

Health-care investors bank on Congress snarling RFK Jr.’s plans

January 17, 2025

As part of its quest to “discover the science of humanity,” the Truveta Genome Project will gather the de-identified genetic data of tens of millions of consented volunteers, health data startup Truveta announced Jan. 13, 2025.

Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers

By Lindsey Leake

January 16, 2025

Entrepreneur and Cost Plus Drugs cofounder Mark Cuban (right) speaks with Andrew Nusca, editorial director of Fortune’s Brainstorm series, at a Brainstorm Tech dinner on Monday, Jan. 6, 2025, in Las Vegas.

Mark Cuban once helped his college friend save almost $10,000 on prescriptions after a ‘horrific car accident’

By Lindsey Leake

January 7, 2025

Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1

Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1

By Jennifer Fields

January 3, 2025

Matt Gaetz speaks in front of a microphone, holding his finger up

Damning 37-page report says Matt Gaetz ‘regularly’ paid for sex and used drugs while he was a member of Congress

By Farnoush Amiri, Lisa Mascaro and The Associated Press

December 23, 2024

Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

By Lindsey Leake

December 20, 2024

Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints

By Ryan Hogg and AFP

December 20, 2024

U.S. life expectancy jumped up by a year thanks to falling drug overdoses and heart disease

U.S. life expectancy jumped up by a year thanks to falling drug overdoses and heart disease

By Mike Stobbe and The Associated Press

December 19, 2024

Donald Trump speaks in front of a podium with a blue sign that said "Trump Vance"

Trump criticizes ‘rich as hell’ pharmacy benefit managers

By Sasha Rogelberg

December 17, 2024

Older man sitting at table holding his arm still as he eats soup

Hope for Parkinson’s disease symptoms is found in late-stage drug study

By Beth Greenfield

December 10, 2024

Trump plans to hit Mexico and Canada with tariffs over immigration. Here’s what the numbers say about border crossings, drugs and crime

Trump plans to hit Mexico and Canada with tariffs over immigration. Here’s what the numbers say about border crossings, drugs and crime

By Rebecca Santana and The Associated Press

November 27, 2024

Oregon towns are banning magic mushrooms as voters sour on drug reform 4 years after the state became the first to legalize psilocybin

Oregon towns are banning magic mushrooms as voters sour on drug reform 4 years after the state became the first to legalize psilocybin

By Claire Rush and The Associated Press

November 22, 2024

Novo Nordisk launches Wegovy in China with prices well below U.S.

Novo Nordisk launches Wegovy in China with prices well below U.S.

By Amber Tong and Bloomberg

November 18, 2024

Most Popular